We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Durable response after just one cycle of belotecan-based chemotherapy in a patient with relapsed primary peritoneal serous carcinoma.
- Authors
Lee, Guk Jin; Min, Ji Won; Seo, Min Wu; Lee, Mi Yeong; Jin, Jong Youl
- Abstract
The efficacy of second-line chemotherapy for relapsed primary peritoneal serous carcinoma has been numerously reported, but reports on durable response after second-line therapy have been rare. We report the case of a 66-year-old woman with relapsed primary peritoneal serous carcinoma who showed durable response after just one cycle of second-line belotecan-based therapy. The response might be a complete pathologic remission. Considering the fact that our patient suffered from neutropenic sepsis during her treatment, we concluded that belotecan-based chemotherapy could be a good option for second-line chemotherapy in some selected patients, so patient selection should be carefully performed due to the toxicity of belotecan.
- Subjects
ANTINEOPLASTIC agents; CISPLATIN; TOMOGRAPHY; TUMOR antigens; DISEASE relapse; PERITONEUM tumors; DISEASE remission
- Publication
Journal of Obstetrics & Gynaecology Research, 2014, Vol 40, Issue 1, p297
- ISSN
1341-8076
- Publication type
Article
- DOI
10.1111/jog.12161